Adults aged 40 years and older with symptoms of cognitive impairment may now qualify for a recently approved blood test for Alzheimer disease.

New positive preclinical studies show that sabizabulin can overcome drug resistance to daraxonrasib with potent anticancer ...

Veru announces sabizabulin's potential as a treatment for daraxonrasib-resistant pancreatic cancer, supported by new ...

A simple blood draw can now help doctors check for the plaques tied to Alzheimer’s.

The long-term study tracked 4,282 adults between the ages of 46 and 75 over a median observation period exceeding 12 years.

Compare the best lead scoring software for 2026, including HubSpot, ZoomInfo, Salesforce, Marketo, 6sense, and ActiveCampaign ...

The approach is solid, but the choice of learning rules, circuit architecture, and sparsity assumptions is not always sufficiently justified, and the model would benefit from a clearer mechanistic ...

Doctors have a new blood test available to help investigate possible Alzheimer’s disease in people who are already showing ...

It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.

Employee retention continues to be a top concern for CHROs and their subordinates, and predictive analytics can carry out use ...